Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Mary Ann Price Killed in Crash at Etiwanda Avenue and Valley Boulevard


2 Vehicles Collide in Fatal Rancho Cucamonga Accident

Rancho Cucamonga, CA (March 1, 2020) – A woman was killed in a crash in Rancho Cucamonga. The fatal accident occurred on the morning of March 1 at Etiwanda Avenue and Valley Boulevard.

A Ford was heading north on Etiwanda Avenue when it hit a Toyota at the intersection. Mary Ann Price, 75, from Fontana, was a passenger in the Toyota. She was taken to a local hospital, where she later died. 

The driver of the Toyota and a passenger in the Ford were hospitalized with unknown injuries. The driver of the Ford suffered minor injuries.

Our heartfelt condolences go out to the friends and loved ones of the Mary Ann Price.

#Rancho Cucamonga

#92335


March 12, 2020

Woman Killed in Pedestrian Crash at Mariposa and R Streets

Victim Hit by Car in Fatal Fresno Accident...


May 26, 2020

3 Injured in Crash at Old Highway 99 and Bailey Road

2 Vehicles Involved in Williams Accident...


May 4, 2020

1 Killed in Crash on Highway 14 Near Soledad Canyon Road

Motorcycle Crashes in Fatal Santa Clarita Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.